These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9352868)

  • 1. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C.
    Gavier B; Martínez-González MA; Riezu-Boj JI; Lasarte JJ; Garcia N; Civeira MP; Prieto J
    Gastroenterology; 1997 Nov; 113(5):1647-53. PubMed ID: 9352868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.
    Bell H; Hellum K; Harthug S; Maeland A; Ritland S; Myrvang B; von der Lippe B; Raknerud N; Skaug K; Gutigard BG; Skjaerven R; Prescott LE; Simmonds P
    Scand J Infect Dis; 1997; 29(1):17-22. PubMed ID: 9112292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low virological response to interferon in children with chronic hepatitis C.
    Pensati P; Iorio R; Botta S; Tuccillo C; Donetto S; Vajro P; Ciarlo G; Vegnente A
    J Hepatol; 1999 Oct; 31(4):604-11. PubMed ID: 10551382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy).
    Magrin S; Craxi A; Fabiano C; Marino L; Fiorentino G; Lo Iacono O; Volpes R; Di Marco V; Almasio P; Vaccaro A; Urdea MS; Wilber JC; Bonura C; Gianguzza F; Capursi V; Filiberti S; Stuyver L; Pagliaro L
    J Hepatol; 1996 Nov; 25(5):583-90. PubMed ID: 8938531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
    Zeuzem S; Lee JH; Franke A; Rüster B; Prümmer O; Herrmann G; Roth WK
    Hepatology; 1998 Apr; 27(4):1149-56. PubMed ID: 9537457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term follow-up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders.
    Yamada M; Fukuda Y; Koyama Y; Nakano I; Urano F; Isobe K; Takamatsu J; Imoto M; Hayakawa T
    Eur J Haematol; 1996 Aug; 57(2):165-70. PubMed ID: 8856094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis.
    Rossini A; Ravaggi A; Biasi L; Agostinelli E; Bercich L; Gazzola GB; Callea F; Radaeli E; Cariani E
    Hepatology; 1997 Oct; 26(4):1012-7. PubMed ID: 9328328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon.
    Camps J; García-Granero M; Riezu-Boj JI; Larrea E; de Alava E; Civeira MP; Castilla A; Prieto J
    J Hepatol; 1994 Jul; 21(1):4-11. PubMed ID: 7963420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C with interferon-alpha by monitoring the response according to viraemia.
    Bonetti P; Chemello L; Antona C; Breda A; Brosolo P; Casarin P; Crivellàro C; Donà G; Martinelli S; Rinaldi R; Zennaro V; Santonastaso M; Urban F; Pontisso P; Alberti A
    J Viral Hepat; 1997 Mar; 4(2):107-12. PubMed ID: 9097266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of HCV viremia in kidney transplant recipients during and after alpha-interferon therapy.
    Izopet J; Rostaing L; Ton-That H; Dubois M; Cazabat M; Charlet JP; Sayada C; Duffaut M; Durand D; Puel J
    Am J Nephrol; 1997; 17(5):417-20. PubMed ID: 9382158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of interferon alfa treatment in chronic hepatitis C in relation to the serum concentration of RNA-HCV and the viral genotype].
    Hermida M; Castro A; López S; Vega P; Pedreira J
    An Med Interna; 1997 Oct; 14(10):500-5. PubMed ID: 9424139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNA.
    Watanabe S; Kobayashi Y; Konishi M; Yokoi M; Kakehashi R; Kaito M; Suzuki S
    Intern Med; 1993 Jul; 32(7):523-9. PubMed ID: 8286827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    Hepatogastroenterology; 1999; 46(26):1094-9. PubMed ID: 10370673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels.
    Silverman AL; Piquette DL; Filipiak CL; Neill JS; Bayati N; Gordon SC
    Am J Gastroenterol; 1997 Oct; 92(10):1793-5. PubMed ID: 9382038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.